Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00440986 |
Recruitment Status
:
Completed
First Posted
: February 27, 2007
Last Update Posted
: March 1, 2007
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Hereditary Hemochromatosis | Procedure: Eritrocytoapheresis | Phase 2 Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 25 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis |
Study Start Date : | April 2003 |
Study Completion Date : | December 2006 |

- To prospectively determine the best choice of tretment in HH
- To evaluate the global outcome according to treatment choice
- To evaluate the outcome of specific clinical features according to treatment choice

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Patiens newly diagnosed having Hereditary Hemochromatosis
Exclusion Criteria:
- Age < 18 yrs.
- Not obese (BMI <30)
- Not consuming alchol beverages,
- Not affected by systemic diseases and known hepatic viruses

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00440986
Italy | |
Department of Transfusion Medicine-San Filippo Neri General Hospital | |
Rome, Italy, 00135 |
Principal Investigator: | Francesco Equitani, M.D. | San Filippo Neri General Hospital |
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: | NCT00440986 History of Changes |
Other Study ID Numbers: |
CMHHPE HH1 |
First Posted: | February 27, 2007 Key Record Dates |
Last Update Posted: | March 1, 2007 |
Last Verified: | February 2007 |
Keywords provided by San Filippo Neri General Hospital:
Clinical Management Phlebotomy Eritrocytoapheresis |
Additional relevant MeSH terms:
Hemochromatosis Metal Metabolism, Inborn Errors Metabolism, Inborn Errors Genetic Diseases, Inborn |
Iron Overload Iron Metabolism Disorders Metabolic Diseases |